Self-administration of bretazenil under progressive-ratio schedules: Behavioral economic analysis of the role intrinsic efficacy plays in the reinforcing effects of benzodiazepines

Drug and Alcohol Dependence

Volumn 113, Issue 2-3, 2011, Pages 157-164

  Licata, Stephanie C ^a   Rowlett, James K ^b  

^a MCLEAN HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Behavioral economics; Benzodiazepine; Bretazenil; Rhesus monkey; Self administration

Indexed keywords

BENZODIAZEPINE DERIVATIVE; BRETAZENIL; MIDAZOLAM; ZOLPIDEM;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; BEHAVIORAL ECONOMICS; CONSUMER ATTITUDE; DRUG SELF ADMINISTRATION; ECONOMIC EVALUATION; ECONOMICS; FEMALE; MALE; NONHUMAN; PRIORITY JOURNAL; REINFORCEMENT; RHESUS MONKEY; SUBSTANCE ABUSE; WORK;

ANIMALS; BENZODIAZEPINES; BENZODIAZEPINONES; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; MACACA MULATTA; MALE; MODELS, ECONOMIC; REINFORCEMENT (PSYCHOLOGY); REINFORCEMENT SCHEDULE; SELF ADMINISTRATION;

MACACA MULATTA;

EID: 78651499947     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2010.07.019     Document Type: Article

References (45)

1. Allison J. Behavioral Economics 1983, Praeger Publishers, New York.
2. Allison J. Response deprivation, reinforcement, and economics. J. Exp. Anal. Behav. 1993, 60:129-140.
3. Allison J., Boulter P. Wage rate, nonlabor income, and labor supply in rats. Learn. Motiv. 1982, 13:324-342.
4. Ator N.A. High-dose discrimination training with midazolam: context determines generalization profile. Pharmacol. Biochem. Behav. 1999, 64:237-243.
5. Ator N.A. Relation between discriminative and reinforcing effects of midazolam, pentobarbital, chlordiazepoxide, zolpidem, and imidazenil in baboons. Psychopharmacology 2002, 163:477-487.
6. Bickel W.K., De Grandpre R.J., Higgins S.T., Hughes J.R. Behavioral economics of drug self-administration. I. Functional equivalence of response requirement and drug dose. Life Sci. 1990, 47:1501-1510.
7. Bickel W.K., Marsch L.A., Caroll M.E. Deconstructing relative reinforcing efficacy and situating the measures of pharmacological reinforcement with behavioral economics: a theoretical perspective. Psychopharmacology 2000, 153:44-56.
8. Bronson M.E. Chlordiazepoxide, but not bretazenil, produces acute dependence, as evidenced by disruptions in schedule-controlled behavior. Pharmacol. Biochem. Behav. 1994, 48:397-401.
9. Busto U., Kaplan H.L., Zawertailo L., Sellers E.M. Pharmacologic effects and abuse liability of bretazenil, diazepam, and alprazolam in humans. Clin. Pharmacol. Ther. 1994, 55:451-463.
10. Centers for Disease Control and Prevention, 2010. Emergency department visits involving nonmedical use of selected prescription drugs-Unites States, 2004-2008. Morbidity and Mortality Weekly Report 59, 705-736.
11. DeGrandpre, R.J., Bickel, W.K., 1996. Drug dependence as consumer demand. In: Green, L., Kagel, G.H. (Eds.), Advances in Behavioral Economics, vol. 3, Substance Use and Abuse. Ablax Publishing Co., Norwood, NJ.
12. English J.A., Rowlett J.K., Woolverton W.L. Unit-price analysis of opioid consumption by monkeys responding under a progressive-ratio schedule of drug injection. J. Exp. Anal. Behav. 1995, 64:361-371.
13. Facklam M., Schoch P., Bonetti E.P., Jenck F., Martin J.R., Moreau J.L., Haefely W.E. Relationship between benzodiazepine receptor occupancy and functional effects in vivo of four ligands of differing intrinsic efficacies. J. Pharmacol. Exp. Ther. 1992, 261:1113-1121.
14. Facklam M., Schoch P., Haefely W.E. Relationship between benzodiazepine receptor occupancy and potentiation of gamma-aminobutyric acid-stimulated chloride flux in vitro of four ligands of differing intrinsic efficacies. J. Pharmacol. Exp. Ther. 1992, 261:1106-1112.
15. Griffiths R.R., Sannerud C.A., Ator N.A., Brady J.V. Zolpidem behavioral pharmacology in baboons: self-injection, discrimination, tolerance and withdrawal. J. Pharmacol. Exp. Ther. 1992, 260:1199-1208.
16. Hursh S.R., Galuska C.M., Winger G., Woods J.H. The economics of drug abuse: a quantitative assessment of drug demand. Mol. Interv. 2005, 5:20-28.
17. Hursh S.R., Raslear T.G., Shurtleff D., Bauman R., Simmons L. A cost-benefit analysis of demand for food. J. Exp. Anal. Behav. 1988, 50:419-440.
18. Hursh S.R., Silberberg A. Economic demand and essential value. Psychol. Rev. 2008, 115:186-198.
19. Hursh S.R., Winger G. Normalized demand for drugs and other reinforcers. J. Exp. Anal. Behav. 1995, 64:373-384.
20. Institute of Laboratory Animal Resources, Commission on Life Sciences, National Research Council, 1996. Guide for the Care and Use of Laboratory Animals, 7th ed. National Academy Press, Washington, DC.
21. Jones G.H., Schneider C., Schneider H.H., Seidler J., Cole B.J., Stephens D.N. Comparison of several benzodiazepine receptor ligands in two models of anxiolytic activity in the mouse: an analysis based on fractional receptor occupancies. Psychopharmacology 1994, 114:191-199.
22. Lelas S., Gerak L.R., France C.P. Discriminative stimulus effects of triazolam and midazolam in rhesus monkeys. Behav. Pharmacol. 1999, 10:39-50.
23. Martin J.R., Jenck F., Moreau J.L. Comparison of benzodiazepine receptor ligands with partial agonistic, antagonistic or partial inverse agonistic properties in precipitating withdrawal in squirrel monkeys. J. Pharmacol. Exp. Ther. 1995, 275:405-411.
24. Martin J.R., Pieri L., Bonetti E.P., Schaffner R., Burkard W.P., Cumin R., Haefely W.E. Ro 16-6028: a novel anxiolytic acting as a partial agonist at the benzodiazepine receptor. Pharmacopsychiatry 1988, 21:360-362.
25. Martin J.R., Schoch P., Jenck F., Moreau J.L., Haefely W.E. Pharmacological characterization of benzodiazepine receptor ligands with intrinsic efficacies ranging from high to zero. Psychopharmacology 1993, 111:415-422.
26. McCabe S.E. Correlates of nonmedical use of prescription benzodiazepine anxiolytics: results from a national survey of U.S. college students. Drug Alcohol Depend. 2005, 79:53-62.
27. McMahon L.R., France C.P. Differential behavioral effects of low efficacy positive GABAA modulators in combination with benzodiazepines and a neuroactive steroid in rhesus monkeys. Br. J. Pharmacol. 2006, 147:260-268.
28. Mirza N.R., Nielsen E.Ø. Do subtype-selective γ-aminobutyric acidA receptor modulators have a reduced propensity to induce physical dependence in mice?. J. Pharmacol. Exp. Ther. 2006, 316:1378-1385.
29. Mirza N.R., Rodgers R.J., Mathiasen L.S. Comparative cue generalization profiles of L-838,417, SL651498, zolpidem, CL218,872, ocinaplon, bretazenil, zopiclone, and various benzodiazepines in chlordiazepoxide and zolpidem drug discrimination. J. Pharmacol. Exp. Ther. 2006, 316:1291-1299.
30. Möhler H. GABA(A) receptor diversity and pharmacology. Cell Tissue Res. 2006, 326:505-516.
31. Moreau J.L., Jenck F., Pieri L., Schoch P., Martin J.R., Haefely W.E. Physical dependence induced in DBA/2J mice by benzodiazepine receptor full agonists, but not by the partial agonist Ro 16-6028. Eur. J. Pharmacol. 1990, 190:269-273.
32. Platt, D.M., Carey, G.J., Spealman, R.D., 2005. Intravenous self-administration techniques in monkeys. In: Enna, S., Williams, M., Ferkany, J., Kenakin, T., Porsolt, R., Sullivan, J. (Eds.), Current Protocols in Neuroscience. Wiley, New York (Unit 9.21).
33. Rijnders H.J., Järbe T.U., Slangen J.L. The pentylenetetrazole-cue antagonist actions of bretazenil (Ro 16-6028) as compared to midazolam. Pharmacol. Biochem. Behav. 1991, 39:129-132.
34. Rodefer J.S., Carroll M.E. Progressive-ration and behavioral economic evaluation of the reinforcing efficacy of orally delivered phencyclidine and ethanol in monkeys: effects of feeding conditions. Psychopharmacology 1996, 128:265-273.
35. Rowlett J.K. A labor-supply analysis of cocaine self-administration under progressive-ratio schedules: antecedents, methodologies, and perspectives. Psychopharmacology 2000, 153:1-16.
36. Rowlett J.K., Lelas S. Comparison of zolpidem and midazolam self-administration under progressive-ratio schedules: consumer demand and labor supply analyses. Exp. Clin. Psychopharmacol. 2007, 15:328-337.
37. Rowlett J.K., Platt D.M., Lelas S., Atack J.R., Dawson G.R. Different GABAA receptor subtypes mediate the anxiolytic, abuse-related, and motor effects of benzodiazepine-like drugs in primates. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:915-920.
38. Rowlett J.K., Rodefer J.S., Spealman R.D. Self-administration of cocaine, alfentanil and nalbuphine under progressive-ratio schedules: consumer demand and labor supply analyses of relative reinforcing effectiveness. Exp. Clin. Psychopharmacol. 2002, 10:367-375.
39. Sannerud C.A., Ator N.A. Drug discrimination analysis of midazolam under a three-lever procedure. II: Differential effects of benzodiazepine receptor agonists. J. Pharmacol. Exp. Ther. 1995, 275:183-193.
40. Schoch P., Moreau J.L., Martin J.R., Haefely W.E. Aspects of benzodiazepine receptor structure and function with relevance to drug tolerance and dependence. Biochem. Soc. Symp. 1993, 59:121-134.
41. Tan K.R., Brown M., Labouèbe, Yvon C., Creton C., Fritschy J.-M., Rudolph U., Lüscher C. Neural bases for addictive properties of benzodiazepines. Nature 2010, 463:769-775.
42. Wafford K.A., Whiting P.J., Kemp J.A. Differences in affinity and efficacy of benzodiazepine receptor ligands at recombinant gamma-aminobutyric acidA receptor subtypes. Mol. Pharmacol. 1993, 43:240-244.
43. Weed M.R., Paul I.A., Dwoskin L.P., Moore S.E., Woolverton W.L. The relationship between reinforcing effects and in vitro effects of D1 agonists in monkeys. J. Pharmacol. Exp. Ther. 1997, 283:29-38.
44. Wilcox K.M., Rowlett J.K., Paul I.A., Ordway G.A., Woolverton W.L. On the relationship between dopamine transporter and the reinforcing effects of local anesthetics: practical and theoretical concerns. Psychopharmacology 2000, 153:139-147.
45. Yakushiji T., Fukuda T., Oyama Y., Akaike N. Effects of benzodiazepines and non-benzodiazepine compounds on the GABA-induced response in frog isolated sensory neurones. Br. J. Pharmacol. 1989, 98:735-740.